Avalo Therapeutics, Inc. (AVTX) Revenue History
Avalo Therapeutics, Inc. (AVTX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $1.15M |
| 2017-12-31 | $27.81M |
| 2018-12-31 | $7.03M |
| 2019-12-31 | $6.75M |
| 2020-12-31 | $6.70M |
| 2021-12-31 | $5.40M |
| 2022-12-31 | $18.05M |
| 2023-12-31 | $1.92M |
| 2024-12-31 | $441.00K |
| 2025-12-31 | $59.00K |
How AVTX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| BNTC | Benitec Biopharma Inc. | $75.00K |
| INO | Inovio Pharmaceuticals Inc. | $65.34K |
| INMB | INmune Bio Inc. | $50.00K |
| ALT | Altimmune Inc. | $41.00K |
| ALLO | Allogene Therapeutics Inc. | $22.00K |
These are five companies in the same sector as AVTX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Avalo Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("AVTX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AVTX | $19.98 | +0.81% | 0.18M |
| 3 | ||||
| 4 | ||||
| 5 |